Liquidia Technologies, Inc.
LQDA US53635D2027
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
62% | 24% | 98% | 2% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Singh Raman O |
25.81 USD |
45,524 Sold |
1,174,974 USD |
15/09/2025 | 15/09/2025 |
Singh Raman O |
29.42 USD |
7,500 Sold |
220,650 USD |
03/09/2025 | 03/09/2025 |
Schundler Russell SR OFF |
29.05 USD |
1,063 Sold |
30,880 USD |
29/08/2025 | 02/09/2025 |
Moomaw Scott CCO |
29.05 USD |
692 Sold |
20,103 USD |
29/08/2025 | 02/09/2025 |
Manning Paul B O |
29.14 USD |
74,230 Sold |
2,163,062 USD |
28/08/2025 | 02/09/2025 |
Kaseta Michael CFO |
29.05 USD |
1,148 Sold |
33,349 USD |
29/08/2025 | 02/09/2025 |
Manning Paul B O |
28.67 USD |
254,038 Sold |
7,283,269 USD |
28/08/2025 | 02/09/2025 |
Moomaw Scott CCO |
28.62 USD |
8,315 Sold |
237,995 USD |
29/08/2025 | 02/09/2025 |
Moomaw Scott CCO |
28.62 USD |
61,685 Sold |
1,765,573 USD |
29/08/2025 | 02/09/2025 |
Adair Jason CBO |
29.05 USD |
451 Sold |
13,102 USD |
11/07/2025 | 02/09/2025 |